Drug Profile
Research programme: tubulin polymerisation inhibitors - Onconova Therapeutics
Alternative Names: ON-015640; ON-24160Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Onconova Therapeutics
- Class Indoles; Small molecules; Sulfonamides; Sulfones
- Mechanism of Action Apoptosis stimulants; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer